triiodothyronine has been researched along with Osteopetrosis in 5 studies
Triiodothyronine: A T3 thyroid hormone normally synthesized and secreted by the thyroid gland in much smaller quantities than thyroxine (T4). Most T3 is derived from peripheral monodeiodination of T4 at the 5' position of the outer ring of the iodothyronine nucleus. The hormone finally delivered and used by the tissues is mainly T3.
3,3',5-triiodo-L-thyronine : An iodothyronine compound having iodo substituents at the 3-, 3'- and 5-positions. Although some is produced in the thyroid, most of the 3,3',5-triiodo-L-thyronine in the body is generated by mono-deiodination of L-thyroxine in the peripheral tissues. Its metabolic activity is about 3 to 5 times that of L-thyroxine. The sodium salt is used in the treatment of hypothyroidism.
Osteopetrosis: Excessive formation of dense trabecular bone leading to pathological fractures; OSTEITIS; SPLENOMEGALY with infarct; ANEMIA; and extramedullary hemopoiesis (HEMATOPOIESIS, EXTRAMEDULLARY).
| Excerpt | Relevance | Reference |
|---|---|---|
| "Biochemical markers of bone remodelling were used to evaluate bone turnover in two types of autosomal dominant osteopetrosis (ADO) at baseline and during stimulation with triiodothyronine (T3)." | 7.70 | Biochemical markers of bone metabolism in benign human osteopetrosis: a study of two types at baseline and during stimulation with triiodothyronine. ( Bollerslev, J; Brixen, K; Djøseland, O; Grodum, E; Haug, E; Ueland, T, 1998) |
| "Biochemical markers of bone remodelling were used to evaluate bone turnover in two types of autosomal dominant osteopetrosis (ADO) at baseline and during stimulation with triiodothyronine (T3)." | 3.70 | Biochemical markers of bone metabolism in benign human osteopetrosis: a study of two types at baseline and during stimulation with triiodothyronine. ( Bollerslev, J; Brixen, K; Djøseland, O; Grodum, E; Haug, E; Ueland, T, 1998) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (40.00) | 18.7374 |
| 1990's | 3 (60.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bollerslev, J | 5 |
| Thomas, S | 1 |
| Grodum, E | 3 |
| Brixen, K | 2 |
| Djøseland, O | 2 |
| Ueland, T | 1 |
| Haug, E | 1 |
| Kvetny, J | 3 |
| Nielsen, HK | 1 |
| Mosekilde, L | 1 |
5 other studies available for triiodothyronine and Osteopetrosis
| Article | Year |
|---|---|
Collagen metabolism in two types of autosomal dominant osteopetrosis during stimulation with thyroid hormones.
Topics: Adult; Alkaline Phosphatase; Biomarkers; Bone Development; Bone Resorption; Collagen; Female; Fibrob | 1995 |
Biochemical markers of bone metabolism in benign human osteopetrosis: a study of two types at baseline and during stimulation with triiodothyronine.
Topics: Adult; Biomarkers; Bone and Bones; Bone Development; Bone Remodeling; Bone Resorption; Female; Genes | 1998 |
Decreased thyroid hormone-stimulated oxygen consumption and glucose uptake in mononuclear blood cells from patients with autosomal dominant osteopetrosis type I.
Topics: Adult; Aged; Blood Glucose; Cells, Cultured; Chromosome Aberrations; Chromosome Disorders; Female; G | 1991 |
Triiodothyronine stimulates urinary excretion of calcium and hydroxyproline in autosomal dominant osteopetrosis.
Topics: Adult; Calcium; Female; Humans; Hydroxyproline; Male; Middle Aged; Osteopetrosis; Phosphates; Triiod | 1988 |
Thyroid hormone resistance in blood monocyte cells and elevated serum T3 in patients with autosomal dominant osteopetrosis.
Topics: Adult; Aged; Female; Humans; Male; Middle Aged; Monocytes; Osteopetrosis; Receptors, Thyroid Hormone | 1988 |